You should be tested for Celiac Disease. Recent studies show a link beteen PBC and undiagnosed CD. Other studies have shown a gluten free diet in many cases can greatly improve liver function for those with liver disease.
Below is an article to give to your doctor. It is worth taking the test for Celiac Disease. Read about CD on my website.
Article from http://www.maladiecoeliaque.com/infcom19.htm
Tissue transglutaminase antibodies and Celiac Disease in patients with primary biliary cirrhosis and autoimmune cholangitis
Costas Chatzicostas, Maria Roussomoustakaki, Dept of Gastroenterology, Univ Hosp, Heraklion Greece; Dimitrios Drygiannakis, Dept of Immunology, Gen Hosp, Rethymnon Greece; Maria Niniraki, Dept of Immunology, Univ Hosp, Heraklion Greece; Mary Koulentaki, Dept of Gastroenterology, Univ Hosp, Heraklion Greece; Maria Tzardi, Dept of Pathology, Univ Hosp, Heraklion Greece; Elias A. Kouroumalis, Dept of Gastroenterology, Univ Hosp, Heraklion Greece
Background: Recent studies have reported an association between celiac disease (CD) and primary biliary cirrhosis (PBC), suggesting the need for screening for one disease when the other is identified. Tissue transglutaminase (tTG)is the main autoantigen recognized by endomysial antibodies (EMA), the best serological marker for CD so far. Aims: To assess the efficacy of IgA antibodies to tTG in screening a group of Cretan patients with PBC and autoimmune cholangitis (AIC) for celiac disease. Materials and methods: Sera from 62 patients with PBC, 17 with AIC, and 100 healthy blood donors were examined for IgA-tTG (ELISA), for IgA-EMA and reticulin (indirect immunofluorescence)and for IgG- and IgA-gliadin andibodies (ELISA). Ten patients with untreated celiac disease served as methological controls. Results: Transglutaminase antibodies were found in 10% of PBC, in 18% of AIC, in all 10 celiacs, but in none of the blood donors. Reticulin and endomysial antibodies were negative in all patients with liver disease and in healthy controls. Intestinal biopsies were performed in 83% of PBC and in all AIC patients who were tTG positive. No evidence of celiac disease was found. Gliadin antibodies were also significantly increased in patients (21% of PBC and 35% of AIC vs 3% in controls, p < 0.0001). Conclusions: Our findings do not support any association between PBC, AIC and CD. In liver disease gliadin and transglutaminase antibodies are not useful in screening for CD, whereas endomysial antibodies and intestinal biopsy remain the gold standard.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.